The first pill shown to treat COVID-19 has moved one step closer to being available to the public. The pharmaceutical company Merck requested FDA emergency authorization Monday for their COVID-19 ...
WASHINGTON (AP) — An experimental COVID-19 drug that could soon become the first U.S.-authorized pill to treat the coronavirus faces one final hurdle Tuesday: A panel of government experts will ...
The U.S. government has agreed to purchase 1.4 million more courses of molnupiravir, Merck’s experimental COVID-19 antiviral drug, for roughly $1 billion, the drugmaker said Nov. 9. The deal is ...
It wasn’t that long ago that people considered Moderna and Pfizer to be saviors. Their work during the COVID-19 pandemic brought on an unusual outpouring of support and goodwill toward the ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback